Neurofibromatosis and Schwannomatosis Therapeutics Market Research...

a adăugat un sunet Home

2026-07-30 07:05:15

Neurofibromatosis and Schwannomatosis Therapeutics Market Research Report and Strategic Forecast

The global Neurofibromatosis and Schwannomatosis Therapeutics Market is set to experience robust expansion, growing from USD 1.1 billion in 2026 to USD 2.3 billion by 2036 at a Compound Annual Growth Rate (CAGR) of 7.7%. The market entered 2026 up from USD 1.0 billion in 2025, catalyzed by the approval of mirdametinib (GOMEKLI)—the second...

0 Commentarii 0 Distribuiri 294 Views 0 previzualizare